Sponsors (71)
Introduced February 11, 2025 by Jim Costa · Last progress February 11, 2025
The bill centralizes federal attention and coordination on epilepsy to improve care, research, and caregiver engagement, but its benefits depend on sustained funding and implementation and carry risks of added taxpayer cost, possible cost-shifting, and privacy/administrative burdens.
People with epilepsy will benefit from a coordinated federal plan that aims to improve diagnosis, treatment, care coordination, and quality of life through aligned research, services, and surveillance.
Increased federal attention and required annual reporting can focus and potentially increase research funding and investments, speeding development of better diagnostics and therapies.
Low-income households with uncontrolled seizures could be more likely to receive financial support or programs if the bill's emphasis on epilepsy's economic burden prompts targeted policy or funding.
Findings, recommendations, and plans may not produce real-world improvements if follow-on funding, enforcement, or implementation mechanisms are lacking—raising expectations without delivering faster access to care.
Implementing and maintaining a federal plan and Advisory Council will likely require additional federal spending, increasing costs to taxpayers.
Framing epilepsy primarily as a high-cost condition could prompt proposals to offset costs by shifting more expenses onto patients or insurers, increasing out-of-pocket burdens.
Based on analysis of 3 sections of legislative text.
Requires HHS to create and lead a national plan for epilepsy, conduct annual assessments, and establish an advisory council to coordinate research, care, and services.
Creates a federally led national plan to prevent, diagnose, treat, and cure epilepsy and to improve functioning and quality of life for people with epilepsy and their caregivers. It directs the Secretary of Health and Human Services to develop and update an integrated plan, coordinate federal research and services, assess progress nationwide (first assessment within 2 years and annually after), and set up an expert Advisory Council to advise on research, care, and services.